BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8546242)

  • 1. Allogeneic transfusion risks in the surgical patient.
    Klein HG
    Am J Surg; 1995 Dec; 170(6A Suppl):21S-26S. PubMed ID: 8546242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transfusion risks and alternatives to transfusion].
    de Stasio G
    Recenti Prog Med; 1992 Jun; 83(6):321-9. PubMed ID: 1496180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks, options, and informed consent for blood transfusion in elective surgery.
    Goodnough LT; Shuck JM
    Am J Surg; 1990 Jun; 159(6):602-9. PubMed ID: 2112343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.
    Kleinman SH; Glynn SA; Higgins MJ; Triulzi DJ; Smith JW; Nass CC; Garratty G; Murphy EL; LeParc GF; Schreiber GB; King MR; Chamberland ME; Nemo GJ
    Transfusion; 2005 Jul; 45(7):1073-83. PubMed ID: 15987350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated hepatitis and AIDS. What is the risk?
    Bove JR
    N Engl J Med; 1987 Jul; 317(4):242-5. PubMed ID: 3110619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion transmitted human T-lymphotropic virus infections.
    Grillner L
    Acta Anaesthesiol Scand Suppl; 1988; 89():16-9. PubMed ID: 3067484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special report: transfusion risks.
    Walker RH
    Am J Clin Pathol; 1987 Sep; 88(3):374-8. PubMed ID: 3630978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of blood and blood products in Scandinavia today.
    Lindholm A
    Acta Anaesthesiol Scand Suppl; 1988; 89():35-8. PubMed ID: 3067487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of the acquired immunodeficiency syndrome after bone-marrow transplantation.
    Atkinson K; Dodds AJ; Concannon AJ; Biggs JC
    Med J Aust; 1987 Nov; 147(10):510-2. PubMed ID: 3316952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood transfusion: control of infectious risks].
    Laperche S; Lefrère JJ; Morel P; Pouchol E; Pozzetto B
    Presse Med; 2015 Feb; 44(2):189-99. PubMed ID: 25547992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
    Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
    Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen inactivation technology: cleansing the blood supply.
    Klein HG
    J Intern Med; 2005 Mar; 257(3):224-37. PubMed ID: 15715679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on transfusion-transmitted viruses.
    Luban NL
    Curr Opin Pediatr; 1998 Feb; 10(1):53-9. PubMed ID: 9529639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery.
    Cohen ND; Muñoz A; Reitz BA; Ness PK; Frazier OH; Yawn DH; Lee H; Blattner W; Donahue JG; Nelson KE
    N Engl J Med; 1989 May; 320(18):1172-6. PubMed ID: 2710190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on recipients of exposure to allogeneic donor leukocytes.
    Dzik WH
    J Clin Apher; 1994; 9(2):135-8. PubMed ID: 7798162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral disease as a complication of blood transfusion.
    Peetermans ME
    Acta Clin Belg; 1985; 40(2):71-4. PubMed ID: 2992194
    [No Abstract]   [Full Text] [Related]  

  • 17. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral risks associated with blood transfusion.
    Sloand EM
    Photochem Photobiol; 1997 Mar; 65(3):428-31. PubMed ID: 9077125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications of blood transfusions.
    Berkman SA
    Semin Oncol; 1984 Mar; 11(1):68-76. PubMed ID: 6326332
    [No Abstract]   [Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.